These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6311699)

  • 21. [Effect of suloctidil on the contractions of isolated rat aortic strips induced by norepinephrine and CaCl2].
    Ishibashi A; Hanagata R; Horii D; Hisayama T; Takayanagi I
    Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):361-73. PubMed ID: 6323288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of glucose on recovery of energy metabolism following hypoxia-oligemia in mouse brain: dose-dependence and carbohydrate specificity.
    Welsh FA; Sims RE; McKee AE
    J Cereb Blood Flow Metab; 1983 Dec; 3(4):486-92. PubMed ID: 6630318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of flunarizine against cerebral hypoxia-anoxia in mice and rats.
    Karasawa A; Kumada Y; Yamada K; Shuto K; Nakamizo N
    J Pharmacobiodyn; 1982 Apr; 5(4):295-300. PubMed ID: 7120030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological properties of suloctidil.
    Roba J; Roncucci R; Lambelin G
    Acta Clin Belg; 1977; 32(1):3-7. PubMed ID: 331823
    [No Abstract]   [Full Text] [Related]  

  • 25. Suloctidil treatment prevents the development of post-traumatic feline spinal cord ischemia.
    Wolf DL; Hall ED
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):139-44. PubMed ID: 2990364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of Ca++-antagonist agents on the cerebral electrical activity during anoxia in the rat.
    Tolu E; Mameli O; Caria MA; Melis F; Anania V; Desole MS
    Pharmacol Res Commun; 1983 Oct; 15(9):833-42. PubMed ID: 6316376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Suloctidil decreases the serotonin concentration in the brain stem of rats with a portacaval shunt].
    Valenzuela Miranda C; Aller Reyero MA; Arias Pérez J; Alsasua del Valle A; Arias Pérez JL; Rodríguez Sánchez JC; Durán Sacristán H
    Rev Esp Enferm Apar Dig; 1988 May; 73(5 Pt 2):547-52. PubMed ID: 2845525
    [No Abstract]   [Full Text] [Related]  

  • 28. [Influence of combined moderate arterial hypoxaemia and moderate hypovolaemic hypotension on cerebral blood flow and cerebral oxidative and energy metabolism in the dog (author's transl)].
    Wiedemann K; Weinhardt F; Hamer J; Wund G; Berlet H; Hoyer S
    Anaesthesist; 1979 Jun; 28(6):290-8. PubMed ID: 37772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of suloctidil on plasma viscosity in rats on an atherogenic diet].
    Drago F; Amico-Roxas M; Russo A; Bianchi A; Mazzoleni G
    Farmaco Prat; 1980 Aug; 35(8):423-6. PubMed ID: 6256204
    [No Abstract]   [Full Text] [Related]  

  • 30. Brain protection against oxygen deficiency by nizofenone.
    Yasuda H; Izumi N; Nakanishi M; Maruyama Y
    Adv Exp Med Biol; 1988; 222():403-10. PubMed ID: 3364265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanism of action of a novel cerebral protective drug against anoxia I. The effect on cerebral energy demand.
    Yasuda H; Nakanishi M; Tsumagari T; Nakajima A; Nakanishi M
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):77-85. PubMed ID: 543750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superior protective effects of phenytoin against hypoxia in a pharmacological screening test.
    Imaizumi S; Suzuki J; Kinouchi H; Yoshimoto T
    Neurol Res; 1988 Mar; 10(1):18-24. PubMed ID: 2899850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.
    Roncucci R; De Hertogh R; Dormandy JA; Doumont J; Gurewich V; Lambelin G; Lansen J; Rottiers R; Souridis E; Van Stalle F; Versee L
    Arzneimittelforschung; 1979; 29(4):682-4. PubMed ID: 582768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of a new prostacyclin analogue OP-2507 against cerebral anoxia and edema in experimental animals.
    Masuda Y; Ochi Y; Ochi Y; Karasawa T; Hatano N; Kadokawa T; Okegawa T
    Eur J Pharmacol; 1986 Apr; 123(3):335-44. PubMed ID: 3013650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of idebenone against hypoxia in mice.
    Kiyota Y; Miyamoto M; Nagaoka A
    Arch Gerontol Geriatr; 1989 May; 8(3):241-6. PubMed ID: 2764641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cerebroprotective agents on cerebral blood flow and on postischemic energy metabolism in the rat brain.
    Bielenberg GW; Beck T; Sauer D; Burniol M; Krieglstein J
    J Cereb Blood Flow Metab; 1987 Aug; 7(4):480-8. PubMed ID: 3611206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of suloctidil on platelet survival time following cardiac valve replacement.
    Col-de Beys C; Ferrant A; Moriau M
    Thromb Haemost; 1981 Aug; 46(2):550-3. PubMed ID: 6272442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Superior protective activity of phenytoin against hypoxia in pharmacological screening test].
    Imaizumi S; Suzuki J; Kinouchi H; Yoshimoto T
    No To Shinkei; 1986 Feb; 38(2):135-43. PubMed ID: 3008792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo antispasmodic activity of Sulcotidil.
    Roba J; Reuse-Blom S; Lambelin G
    Arch Int Pharmacodyn Ther; 1976 May; 221(1):54-9. PubMed ID: 962430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo effect of suloctidil as an antiplatelet agent.
    Stelzer MR; Burns TS; Saunders RN
    Thromb Haemost; 1979 May; 41(3):465-74. PubMed ID: 462414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.